BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27033677)

  • 1. A retrospective study of the epidemiology and clinical manifestation of invasive aspergillosis in a major tertiary care hospital in Bahrain.
    Alsalman J; Zaid T; Makhlooq M; Madan M; Mohamed Z; Alarayedh A; Ghareeb A; Kamal N
    J Infect Public Health; 2017; 10(1):49-58. PubMed ID: 27033677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.
    Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Cardoso T; Paiva JA; Blasco-Navalpotro M; De Laere E; Dimopoulos G; Rello J; Vogelaers D; Blot SI;
    Crit Care; 2015 Jan; 19(1):7. PubMed ID: 25928694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S; Thibbadee C; Santanirand P
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
    Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
    Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.
    Hsiue HC; Wu TH; Chang TC; Hsiue YC; Huang YT; Lee PI; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1319-26. PubMed ID: 21997774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.
    Park JH; Ryu SH; Lee JY; Kim HJ; Kwak SH; Jung J; Lee J; Sung H; Kim SH
    Antimicrob Resist Infect Control; 2019; 8():88. PubMed ID: 31161035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients.
    Loschi M; Thill C; Gray C; David M; Bagatha MF; Chamseddine A; Contentin N; Jardin F; Lanic H; Lemasle E; Lenain P; Stamatoullas A; Tilly H; Lepretre S
    Mycopathologia; 2015 Jun; 179(5-6):337-45. PubMed ID: 25637199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
    Anugulruengkitt S; Trinavarat P; Chantranuwat P; Sritippayawan S; Pancharoen C; Thanyawee P
    J Med Assoc Thai; 2016 Feb; 99(2):150-8. PubMed ID: 27249894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.
    Reinwald M; Spiess B; Heinz WJ; Heussel CP; Bertz H; Cornely OA; Hahn J; Lehrnbecher T; Kiehl M; Laws HJ; Wolf HH; Schwerdtfeger R; Schultheis B; Burchardt A; Klein M; Dürken M; Claus B; Schlegel F; Hummel M; Hofmann WK; Buchheidt D
    J Clin Microbiol; 2013 Dec; 51(12):4178-85. PubMed ID: 24108612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.
    Denis B; Guiguet M; de Castro N; Mechaï F; Revest M; Melica G; Costagliola D; Lortholary O;
    Clin Infect Dis; 2015 Oct; 61(8):1273-80. PubMed ID: 26123932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domestic mould exposure and invasive aspergillosis-air sampling of Aspergillus spp. spores in homes of hematological patients, a pilot study.
    Schweer KE; Jakob B; Liss B; Christ H; Fischer G; Vehreschild M; Cornely OA; Vehreschild JJ
    Med Mycol; 2016 Aug; 54(6):576-83. PubMed ID: 26941254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).
    Lortholary O; Gangneux JP; Sitbon K; Lebeau B; de Monbrison F; Le Strat Y; Coignard B; Dromer F; Bretagne S;
    Clin Microbiol Infect; 2011 Dec; 17(12):1882-9. PubMed ID: 21668573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
    Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
    Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
    Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
    Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
    Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.
    Rocchi S; Reboux G; Larosa F; Scherer E; Daguindeau E; Berceanu A; Deconinck E; Millon L; Bellanger AP
    Indoor Air; 2014 Dec; 24(6):652-61. PubMed ID: 24621176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
    Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
    Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive aspergillosis in developing countries.
    Chakrabarti A; Chatterjee SS; Das A; Shivaprakash MR
    Med Mycol; 2011 Apr; 49 Suppl 1():S35-47. PubMed ID: 20718613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.
    Luong ML; Chaparro C; Stephenson A; Rotstein C; Singer LG; Waters V; Azad S; Keshavjee S; Tullis E; Husain S
    Transplantation; 2014 Feb; 97(3):351-7. PubMed ID: 24305637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
    Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
    J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.